Cardiff Oncology, Inc. (CRDF) AI Dilution Summary

Cash was $34,520,000 at 2026-06-30 against estimated monthly burn of $3,921,667. The company raised $10,050,000 gross in a registered direct offering that closed 2026-07-16, placed by H.C. Wainwright & Co., LLC. Its funding channel is an active ATM program with Jefferies LLC, authorised to $150,000,000. Through 2026-08-26, 132,274 shares had been sold since the program began; sales after 2026-08-26 are not yet reported.